Recommendations Enable Faster & More Confident CooperVision® clariti® 1 Day Multifocal Fits by ECPs
PLEASANTON, Calif., February 21, 2019—A new clinical study has determined that clariti® 1 day multifocal contact lens power recommendations generated by CooperVision’s OptiExpert™ app closely matched eye care professional (ECP) recommendations following the fitting guide, both at initial fit and follow-up visit. These findings indicate that 100% of wearers can now be successfully fitted with clariti® 1 day multifocal using two pairs of trial lenses or less, thanks to the innovative app’s recommendations.
Conducted by the independent Centre for Ocular Research & Education (CORE), the study confirmed the ability of OptiExpert™ to deliver fast, accurate results with presbyopic patients, ultimately reducing chair time. Results were first published at the recent American Academy of Optometry Annual Meeting and are now being shared more widely by CooperVision in conjunction with OptiExpert’s™ expanded global availability.
The efficient and easy-to-use app, available for iPhone, iPad and Android mobile and tablet devices, includes multiple additional features depending on the country in which it is used. These include a digital version of the Efron Grading Scales, straightforward multifocal and toric calculators, and oxygen profiles to display the oxygen transmissibility of a selected range of lenses. It also offers the ability to securely store images of a patient’s eye condition, as well as recommendations from CooperVision brands including Biofinity®, clariti®, Avaira®, Biomedics®, and Proclear®.
Available in 15 languages and 79 countries worldwide, OptiExpert™ is actively used by more than 25,000 eye care professionals every month. Google Play reviewers have awarded it 4.5 of 5 stars.
“We’re delighted that the study findings reinforce the accuracy of our innovative OptiExpert™ app. It adds another dimension to how we partner with ECPs to save valuable chair time and create a better wearer experience,” said Gary Orsborn, OD, MS, FAAO, FBCLA, Vice President, Global Professional & Clinical Affairs, CooperVision.
# # #
OptiExpert™ is an educational, reference and information tool for eye care professionals. ECPs may choose to use the app in connection with their own patient evaluation, but it is not intended to be relied upon for clinical decision-making. OptiExpert™ is not intended as and does not constitute medical or optometric advice nor is it intended to replace the patient evaluation performed by an eye care professional.
CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit coopervision.com.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, Calif., Cooper has more than 12,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Mike McDougall, APR, Fellow PRSA
McDougall Communications for CooperVision, Inc.
email@example.com or +1-585-434-2150